PVLA EBITDA Growth

Palvella Therapeutics Inc · EBITDA Growth

PVLA logo

PVLA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-157.11%
PVLA TTM EBITDA YoY % (59.10% → -157.11%)
High-resolution chart · PNG

PVLA ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Palvella Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-157.1142%
-153.0703%
-179.383%
-56.0801%
-0.0206%
-24.2367%
59.099%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.